ExoDx Prostate Evaluation in Active Surveillance Patient Population

ExoDx Prostate Evaluation in Active Surveillance Patient Population

The goal of this observational study is to test whether the ExoDx Prostate test add value in biopsy decision making to patients with prostate cancer on an active surveillance regimen.

The current trial seeks to evaluate the role of the ExoDx Prostate test in men with low and favorable intermediate prostate cancer undergoing an active surveillance regimen.

Inclusion Criteria:

• Male, 45+ years of age diagnosed with low-grade or favorable-intermediate prostate cancer and on an active surveillance regimen

Exclusion Criteria:

• Clinical symptoms of urinary tract infection at time of enrollment.
• History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment.
• Known hepatitis or HIV
• History of concurrent renal/bladder tumors